Allogeneic haematopoietic stem cell transplantation in late-onset metachromatic leukodystrophy.
Comparing the long-term outcomes of the largest European cohort of HSCT-treated and untreated late-juvenile and adult MLD patients provides an evidence base for future comparison with innovative therapies and underscores the importance of early diagnosis and intervention.